Skip to main content
Caplight Logo









Pumpkinseed

Pumpkinseed

Private
Palo Alto, CaliforniaHealthcare & Life Scienceshttps://www.pumpkinseed.bio/

Last Round

Series A

May 5, 2026

Total Funding Raised

$36.4M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Pumpkinseed is a biotechnology company that provides a nanophotonic chip platform for de novo protein sequencing.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Biotech Equipment

Business Model

B2G

Customer Profile

Government Contracts, Services & Consulting, Hardware + Subscription, Data as a Service

AI Layer

Application

Keywords

protein sequencingde novo protein sequencingproteomics platformnanophotonic chipnext-gen proteomicssingle-molecule sequencingbiomarker discoverydrug discoveryproteomic datachip-based proteomicsRaman spectroscopydigital proteomicsbiosecuritynanophotonicsprecision medicineBio-AIbiothreat detection

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Pumpkinseed Comparables

Compare Pumpkinseed with similar companies based on industry and business-model similarity.

Pumpkinseed comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Glyphic Biotechnologies
84%
Erisyon
84%
Primary Bioscience
84%

Pumpkinseed Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMay 5, 2026
GrantDec 10, 2025
SeedSep 25, 2025
GrantAug 14, 2025
GrantJun 1, 2025
Grant
Sep 22, 2023

Pumpkinseed Investors

Notable investors and investment history

Pumpkinseed investors
InvestorRounds
National Cancer InstituteGrant
NFXSeries A, Seed
Future VenturesSeed, Series A
ADVenturesSeries A
Stanford UniversitySeries A
Public Health Emergency Medical Countermeasures EnterpriseGrant
Base4 CapitalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 5, 2026

    $20M round led by Future Ventures and NFX.

  • Sep 25, 2025

    $12M round led by NFX

Pumpkinseed Filings

Explore SEC and related filing metadata, where available.

Pumpkinseed filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Pumpkinseed's valuation, stock price, and market status.

Is Pumpkinseed a public or private company?

Pumpkinseed is a private company.

What is the current stock price of Pumpkinseed?

Pumpkinseed is a private company with no public stock price. No recent secondary market data is available.

How much is Pumpkinseed worth (valuation)?

Valuation information for Pumpkinseed is not publicly available.

Can I buy Pumpkinseed stock?

Pumpkinseed shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Pumpkinseed's last funding round?

Pumpkinseed's most recent funding round was Series A on May 5, 2026.

Who are the main investors in Pumpkinseed?

Key investors in Pumpkinseed include NFX, Future Ventures.

Will Pumpkinseed IPO soon?

No public IPO plans have been announced for Pumpkinseed.

How can I track Pumpkinseed secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Pumpkinseed's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersPalo Alto, California
Employee Range14
Year Founded2021
Last FundingMay 5, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?